Cutaneous melanoma is one of the most aggressive and lethal forms of skin cancer. Some specific driver mutations have been described in multiple oncogenes including BRAF and NRAS that are mutated in 60–70% and 15–20% of melanoma, respectively. The aim of this study was to evaluate the role of Small Heat Shock Protein B8 (HSPB8) on cell growth and migration of both BLM (BRAFwt/NRASQ61R) and A375 (BRAFV600E/NRASwt) human melanoma cell lines. HSPB8 is a member of the HSPB family of chaperones involved in protein quality control (PQC) system and contributes to chaperone assisted selective autophagy (CASA) as well as in the regulation of mitotic spindle. In cancer, HSPB8 has anti- or pro-tumoral action depending on tumor type. In melanoma cell lines characterized by low HSPB8 levels, we demonstrated that the restoration of HSPB8 expression causes cell growth arrest, reversion of EMT (Epithelial-Mesenchymal Transition)-like phenotype switching and antimigratory effect, independently from the cell mutational status. We demonstrated that HSPB8 regulates the levels of the active prenylated form of NRAS in NRAS-mutant and NRAS-wild-type melanoma cell lines. Consequently, the inhibition of NRAS impairs the activation of Akt/mTOR pathway inducing autophagy activation. Autophagy can play a dual role in regulating cell death and survival. We have therefore demonstrated that HSPB8-induced autophagy is a crucial event that counteracts cell growth in melanoma. Collectively, our results suggest that HSPB8 has an antitumoral action in melanoma cells characterized by BRAF and NRAS mutations.

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy / R.M. Cristofani, M. Piccolella, M. MONTAGNANI MARELLI, B. Tedesco, A. Poletti, R.M. Moretti. - In: CELL DEATH & DISEASE. - ISSN 2041-4889. - 13:11(2022), pp. 973.1-973.15. [10.1038/s41419-022-05365-9]

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

R.M. Cristofani
Primo
;
M. Piccolella
Secondo
;
M. MONTAGNANI MARELLI;B. Tedesco;A. Poletti
Penultimo
;
R.M. Moretti
Ultimo
2022

Abstract

Cutaneous melanoma is one of the most aggressive and lethal forms of skin cancer. Some specific driver mutations have been described in multiple oncogenes including BRAF and NRAS that are mutated in 60–70% and 15–20% of melanoma, respectively. The aim of this study was to evaluate the role of Small Heat Shock Protein B8 (HSPB8) on cell growth and migration of both BLM (BRAFwt/NRASQ61R) and A375 (BRAFV600E/NRASwt) human melanoma cell lines. HSPB8 is a member of the HSPB family of chaperones involved in protein quality control (PQC) system and contributes to chaperone assisted selective autophagy (CASA) as well as in the regulation of mitotic spindle. In cancer, HSPB8 has anti- or pro-tumoral action depending on tumor type. In melanoma cell lines characterized by low HSPB8 levels, we demonstrated that the restoration of HSPB8 expression causes cell growth arrest, reversion of EMT (Epithelial-Mesenchymal Transition)-like phenotype switching and antimigratory effect, independently from the cell mutational status. We demonstrated that HSPB8 regulates the levels of the active prenylated form of NRAS in NRAS-mutant and NRAS-wild-type melanoma cell lines. Consequently, the inhibition of NRAS impairs the activation of Akt/mTOR pathway inducing autophagy activation. Autophagy can play a dual role in regulating cell death and survival. We have therefore demonstrated that HSPB8-induced autophagy is a crucial event that counteracts cell growth in melanoma. Collectively, our results suggest that HSPB8 has an antitumoral action in melanoma cells characterized by BRAF and NRAS mutations.
HSPB8; melanoma; AUTOPHAGY; proteasome; migration; proliferation; invasiveness; cancer; BAG3
Settore BIO/13 - Biologia Applicata
Settore BIO/09 - Fisiologia
FON_NAZ19APOLE_03 - Alternative translation initiation as a novel strategy to block toxicity of the mutant Androgen Receptor in SBMA - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2019
INTLI19RCRIS_01 - Selective translation of androgen receptor isoform A to prevent polyQ mediated toxicity in Kennedy’s disease - CRISTOFANI, RICCARDO MARIA - INTLI - Finanziamenti internazionali - 2019
FON_NAZ19APOLE_01 - Targeting RAN translation in ALS (Target-RAN) - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2019
AL_RIC18APOLE_01 - Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial (Co-ALS) - POLETTI, ANGELO - AL_RIC - Bandi da altri enti di ricerca - 2018
INTLI21APOLE_01 - The involvement of the small heat shock protein HSPB8 in amyotrophic lateral sclerosis - POLETTI, ANGELO - INTLI - Finanziamenti internazionali - 2021
PRIN201719APOLE_01 - The interplay between the “rna/protein quality control system” and “exosomes” as a spreading mechanism in amyotrophic lateral sclerosis (EX_ALS) - POLETTI, ANGELO - PRIN2017 - PRIN bando 2017 - 2019
FON_NAZ19APOLE_02 - Membrane-less organelle pathology in ALS: identification of causes and rescuing factors (MLOMALS) - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2019
FON_NAZ17APOLE_01 - Translating molecular mechanisms into ALS risk and patient's well-being - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2017
DECC18ACORS_01 - Dipartimenti di Eccellenza 2018-2022 - Dipartimento di SCIENZE FARMACOLOGICHE E BIOMOLECOLARI - CORSINI, ALBERTO - DECC - Bando Dipartimenti di Eccellenza - 2018
18-nov-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
Finale Moretti.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 5.16 MB
Formato Adobe PDF
5.16 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/946048
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact